154 related articles for article (PubMed ID: 20871626)
1. Induction of antitumor immunity against mouse carcinoma by baculovirus-infected dendritic cells.
Suzuki T; Oo Chang M; Kitajima M; Takaku H
Cell Mol Immunol; 2010 Nov; 7(6):440-6. PubMed ID: 20871626
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of baculovirus-infected dendritic cells against human pancreatic carcinoma.
Fujihira A; Suzuki T; Chang MO; Moriyama T; Kitajima M; Takaku H
Gene Ther; 2014 Sep; 21(9):849-54. PubMed ID: 25009006
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H
Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483
[TBL] [Abstract][Full Text] [Related]
4. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
You J; Wang CL; Hao XS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
[TBL] [Abstract][Full Text] [Related]
5. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
Zhang W; He L; Cao X
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells pulsed with placental gp96 promote tumor-reactive immune responses.
Zheng H; Liu L; Zhang H; Kan F; Wang S; Li Y; Tian H; Meng S
PLoS One; 2019; 14(1):e0211490. PubMed ID: 30703157
[TBL] [Abstract][Full Text] [Related]
7. Induction of natural killer cell-dependent antitumor immunity by the Autographa californica multiple nuclear polyhedrosis virus.
Kitajima M; Abe T; Miyano-Kurosaki N; Taniguchi M; Nakayama T; Takaku H
Mol Ther; 2008 Feb; 16(2):261-8. PubMed ID: 18059370
[TBL] [Abstract][Full Text] [Related]
8. Baculovirus activates murine dendritic cells and induces non-specific NK cell and T cell immune responses.
Suzuki T; Chang MO; Kitajima M; Takaku H
Cell Immunol; 2010; 262(1):35-43. PubMed ID: 20060108
[TBL] [Abstract][Full Text] [Related]
9. TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells.
Narusawa M; Inoue H; Sakamoto C; Matsumura Y; Takahashi A; Inoue T; Watanabe A; Miyamoto S; Miura Y; Hijikata Y; Tanaka Y; Inoue M; Takayama K; Okazaki T; Hasegawa M; Nakanishi Y; Tani K
Cancer Immunol Res; 2014 Jun; 2(6):568-80. PubMed ID: 24830413
[TBL] [Abstract][Full Text] [Related]
10. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.
Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X
Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors.
Sun QF; Zhao XN; Peng CL; Hao YT; Zhao YP; Jiang N; Xue H; Guo JZ; Yun CH; Cong B; Zhao XG
Oncol Rep; 2015 Nov; 34(5):2289-95. PubMed ID: 26323510
[TBL] [Abstract][Full Text] [Related]
12. Silencing IDO2 in dendritic cells: A novel strategy to strengthen cancer immunotherapy in a murine lung cancer model.
Liu Y; Xu P; Liu H; Fang C; Guo H; Chen X; Tan M; Zhang Y; Min W
Int J Oncol; 2020 Aug; 57(2):587-597. PubMed ID: 32468023
[TBL] [Abstract][Full Text] [Related]
13. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity.
Cao X; Zhang W; He L; Xie Z; Ma S; Tao Q; Yu Y; Hamada H; Wang J
J Immunol; 1998 Dec; 161(11):6238-44. PubMed ID: 9834111
[TBL] [Abstract][Full Text] [Related]
14. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of antigen-presenting capacity and antitumor immunity of dendritic cells pulsed with autologous tumor-derived RNA in mice.
Minami T; Nakanishi Y; Izumi M; Harada T; Hara N
J Immunother; 2003; 26(5):420-31. PubMed ID: 12973031
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells engineered to express GITRL enhance therapeutic immunity in murine Lewis lung carcinoma.
Ma J; Wang S; Ma B; Mao C; Tong J; Yang M; Wu C; Jiao Z; Lu L; Xu H
Cancer Lett; 2011 Feb; 301(2):142-50. PubMed ID: 21186078
[TBL] [Abstract][Full Text] [Related]
17. A new cancer immunotherapy via simultaneous DC-mobilization and DC-targeted IDO gene silencing using an immune-stimulatory nanosystem.
Zhang Y; Fu J; Shi Y; Peng S; Cai Y; Zhan X; Song N; Liu Y; Wang Z; Yu Y; Wang Y; Shi Q; Fu Y; Yuan K; Zhou N; Joshi R; Ichim TE; Min W
Int J Cancer; 2018 Oct; 143(8):2039-2052. PubMed ID: 29752722
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic progenitor kinase 1 is a negative regulator of dendritic cell activation.
Alzabin S; Bhardwaj N; Kiefer F; Sawasdikosol S; Burakoff S
J Immunol; 2009 May; 182(10):6187-94. PubMed ID: 19414772
[TBL] [Abstract][Full Text] [Related]
20. Optimized biodegradable polymeric reservoir-mediated local and sustained co-delivery of dendritic cells and oncolytic adenovirus co-expressing IL-12 and GM-CSF for cancer immunotherapy.
Oh E; Oh JE; Hong J; Chung Y; Lee Y; Park KD; Kim S; Yun CO
J Control Release; 2017 Aug; 259():115-127. PubMed ID: 28336378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]